Ginkgo Bioworks Holdings annual total debt
2020
2021
2022
2023
2024
2025
Ginkgo Bioworks Holdings Total Debt Growth & History (DNA)
Ginkgo Bioworks Holdings's total debt was $439.9M for fiscal 2025.
View full Ginkgo Bioworks Holdings company overviewGinkgo Bioworks Holdings annual total debt history
| Fiscal year | Period ended | Total debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $439.9M | −$27.9M | −5.96% |
| 2024 | 2024-12-31 | $467.8M | $225.5M | +93.09% |
| 2023 | 2023-12-31 | $242.2M | −$201.8M | −45.45% |
| 2022 | 2022-12-31 | $444.1M | $421.8M | +1892.97% |
| 2021 | 2021-12-31 | $22.3M | $5.8M | +34.90% |
| 2020 | 2020-12-31 | $16.5M | — | — |
Ginkgo Bioworks Holdings quarterly total debt
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $404.1M | −$24.7M | −5.76% |
| Q1 2026 | 2026-03-31 | $410.7M | −$23.9M | −5.49% |
| Q4 2025 | 2025-12-31 | $439.9M | −$27.9M | −5.96% |
| Q3 2025 | 2025-09-30 | $422.9M | −$22.7M | −5.10% |
| Q2 2025 | 2025-06-30 | $428.8M | −$23.4M | −5.18% |
| Q1 2025 | 2025-03-31 | $434.6M | $200.1M | +85.32% |
| Q4 2024 | 2024-12-31 | $467.8M | $225.5M | +93.09% |
| Q3 2024 | 2024-09-30 | $445.6M | $41.9M | +10.39% |
| Q2 2024 | 2024-06-30 | $452.3M | $41.3M | +10.06% |
| Q1 2024 | 2024-03-31 | $234.5M | −$169.6M | −41.97% |
| Q4 2023 | 2023-12-31 | $242.2M | −$201.8M | −45.45% |
| Q3 2023 | 2023-09-30 | $403.7M | $343.8M | +574.55% |
| Q2 2023 | 2023-06-30 | $410.9M | $359.4M | +697.24% |
| Q1 2023 | 2023-03-31 | $404.1M | $376.8M | +1379.72% |
| Q4 2022 | 2022-12-31 | $444.1M | $421.8M | +1892.97% |
| Q3 2022 | 2022-09-30 | $59.8M | $43.6M | +267.85% |
| Q2 2022 | 2022-06-30 | $51.5M | — | — |
| Q1 2022 | 2022-03-31 | $27.3M | — | — |
| Q4 2021 | 2021-12-31 | $22.3M | $5.8M | +34.90% |
| Q3 2021 | 2021-09-30 | $16.3M | — | — |
| Q4 2020 | 2020-12-31 | $16.5M | — | — |
Ginkgo Bioworks Holdings total debt trends
Over the last five fiscal years, Ginkgo Bioworks Holdings's total debt increased from $16.5M to $439.9M, a change of $423.4M. The latest reported quarter, Q2 2026, shows $404.1M.
About the metric
What total debt means
Total debt measures a company’s reported interest-bearing borrowing obligations at a reporting-period end. It can include short-term borrowings, current maturities, long-term debt, and finance lease obligations when they are included in the company’s debt facts.
Calculation and source
SEC-reported and combined total debt
TickerStat uses a reported aggregate debt value when available. Otherwise, it combines non-overlapping current and noncurrent debt facts from SEC filings. Total liabilities are not treated as debt, and missing debt is not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ginkgo Bioworks Holdings source filings ↗Community posts
Ginkgo joins a federally backed RNA-manufacturing project worth up to $17.5 million
Ginkgo Bioworks ($DNA) received a subcontract worth up to $17.5 million to participate in an ARPA-H program focused on RNA manufacturing. Waterfall Scientific is the prime contractor. The project, called ESCALATOR, is intended to combine co ...